Abstract
Neurofibromatosis type 1 (NFI) is a common, autosomal dominant genetic disorder with a variety of highly variable symptoms including cutaneous manifestations (such as cafe au lait spots), Lisch nodules, plexiform neurofibromas, skeletal abnormalities, an increased risk for malignancy, and the development of learning disabilities. The wide clinical variability of expression of the disease phenotype and high (spontaneous) mutation rate of the NFI gene indicate that careful clinical examination of patients and family members is necessary to provide an accurate diagnosis of the disease. Since very few NFI mutations have been identified, and with the apparent lack of a predominant mutation in this large, highly mutable gene, molecular diagnosis of NFI will continue to be based on haplotypes using linkage analysis. Here we report our experiences while providing a molecular diagnostic service for NF1 in the ethnically diverse region of south-western Ontario. Molecular diagnoses with at least one informative probe/enzyme combination are reported for 19 families including two families requesting prenatal diagnosis for NFl. We have augmented the classical Southern based approach to linkage analysis with the use of PCR based assays for molecular linkage. Furthermore, criteria have been established in our laboratory for executing molecular linkage based on heterozygosity values, recombination fractions, and the use of intragenic probes/markers. (J Med Genet 1993; 30:363-8) Neurofibromatosis type 1 (NF1) is a common, autosomal dominant genetic disorder with highly variable symptoms which include a variety of cutaneous manifestations (cafe au lait spots, axillary freckling and dermal neurofibromas), Lisch nodules, plexiform neurofibromas, and skeletal abnormalities.' There is an increased risk for malignancy in the form of neurofibrosarcoma, optic glioma, and certain paediatric leukaemias,2 and a proportion of affected subjects manifest learning disabilities. *Probe/enzyme combinations for which a PCR based assay has been developed.
Inf= ratio of families in which probe was informative compared to total families tested. 
